An atypical mole is a mole that looks different from the ordinary round, evenly colored moles most people have. Clinically called a dysplastic nevus, it tends to be larger, flatter, and more uneven in color and shape. Atypical moles are not cancer, but having them raises your risk of developing melanoma, the most serious form of skin cancer.
How Atypical Moles Look Different
A common mole is usually small, round or oval, a single shade of brown, and has a clean border where it meets normal skin. An atypical mole breaks one or more of those rules. It’s often larger than 6 millimeters (roughly the width of a pencil eraser), with borders that fade or blur into the surrounding skin rather than forming a crisp edge. The color can be uneven, mixing shades of pink, tan, and dark brown within the same mole, and parts of it may be raised while the rest stays flat.
Dermatologists use a set of visual markers known as the ABCDE criteria to flag moles that need a closer look:
- Asymmetry: one half doesn’t match the other
- Border: edges are ragged, notched, or blurred
- Color: multiple shades of brown, tan, pink, or even areas of white, gray, red, or blue
- Diameter: wider than 6 millimeters, or growing
- Evolving: changing in size, shape, or color over time
An atypical mole may hit one or two of these criteria and still be completely benign. The ABCDE features overlap between atypical moles and early melanoma, which is exactly why any mole that checks several of these boxes deserves professional evaluation.
The Link to Melanoma Risk
Having atypical moles doesn’t mean you have or will get skin cancer, but it does shift your odds. A meta-analysis of case-control studies found that a single atypical mole raises the relative risk of melanoma by about 1.45 times compared to having none. That number climbs steeply with count: five atypical moles push the relative risk to 6.36 times higher.
The risk exists on a spectrum. At one end is a person with one or two atypical moles and no family history of melanoma, whose overall risk remains modest. At the other end is a hereditary condition called Familial Atypical Multiple Mole-Melanoma (FAMMM) syndrome, where people typically have 50 or more moles, many with atypical features, plus one or more close relatives who have had melanoma. People with FAMMM who carry a specific gene mutation in a tumor suppressor gene called CDKN2A face up to a 90% lifetime risk of developing melanoma by age 80 and a roughly 20% increased risk of pancreatic cancer by age 75.
Most people with a few atypical moles are nowhere near that end of the spectrum. But knowing where you fall helps you and your dermatologist decide how closely to monitor your skin.
What Happens at the Cellular Level
All moles form when melanocytes, the pigment-producing cells in your skin, cluster together instead of spreading out evenly. In a common mole, these clusters are well organized and genetically stable. In an atypical mole, the melanocytes grow in slightly more disordered patterns and carry additional genetic changes beyond the single mutation that typically kicks off a normal mole.
A single mutation is enough to start a mole but not enough to cause melanoma. The concern with atypical moles is that their cells may sit one step further along the genetic path from benign mole toward cancer. The World Health Organization now uses the term “melanocytoma” for growths that have progressed genetically beyond a simple mole but aren’t frankly malignant. These intermediate stages likely carry a higher chance of eventually transforming, which is why atypical moles warrant monitoring even when they’re currently harmless.
How Atypical Moles Are Evaluated
Dermatologists often use what’s called the “ugly duckling” approach during skin exams. Rather than evaluating each mole in isolation, they compare all your moles to one another. Most of a person’s moles tend to share a similar look. A mole that stands out from the rest, the “ugly duckling,” gets flagged for closer inspection, even if it doesn’t look alarming on its own.
If a mole looks suspicious, a biopsy is the only way to know what’s happening under the surface. A small sample of the mole is removed and examined under a microscope for signs of disordered cell growth. Pathologists typically grade the level of atypia as mild, moderate, or severe, and this grading helps guide the next step.
There is no single, universally accepted guideline for which atypical moles must be biopsied or fully removed. The American Academy of Dermatology’s current clinical guideline on melanoma does not specifically address the management of atypical moles, and consensus-based guidelines on this question are relatively dated. In practice, decisions tend to be individualized. A mole graded as mildly atypical on biopsy with clean margins may simply be watched over time, while one graded as severely atypical is more likely to be completely excised as a precaution.
Monitoring Your Skin Over Time
If you have atypical moles, routine monitoring becomes one of the most effective things you can do. Monthly skin self-exams help you catch changes early, when they’re easiest to address. The goal isn’t to diagnose yourself but to notice when something shifts. A mole that starts growing, darkens unevenly, develops a new border irregularity, or begins to itch or bleed is worth getting checked promptly.
For a thorough self-exam, check your entire body in a well-lit room with a full-length mirror and a hand mirror for hard-to-see spots like your back, scalp, and the soles of your feet. Photographing your moles over time gives you a reliable reference point. Changes that happen gradually over months can be hard to spot from memory alone, but comparing photos side by side makes even subtle shifts obvious.
Your dermatologist will also recommend a schedule for professional skin checks based on your personal risk profile. Someone with many atypical moles or a family history of melanoma will typically be seen more frequently than someone with just one or two. Some dermatologists use a technique called dermoscopy, a handheld magnifying tool with polarized light, to examine mole structures that aren’t visible to the naked eye, and may take standardized photos at each visit to track changes precisely.
What to Do if You Have Atypical Moles
Having atypical moles puts you in a higher-awareness category, not a crisis. The vast majority of atypical moles never become melanoma. What makes them clinically important is that they serve as a marker: your skin is telling you it’s more prone to producing unusual melanocyte growth, and that means you benefit from paying closer attention than the average person.
Sun protection matters more for you than for someone with only common moles. Ultraviolet radiation drives the kind of DNA damage in melanocytes that can push an atypical mole further along the path toward malignancy. Broad-spectrum sunscreen, protective clothing, and avoiding peak sun hours all reduce that cumulative damage over time. None of this guarantees prevention, but it meaningfully lowers the odds.
If you’ve never had your moles evaluated professionally, a baseline full-body skin exam gives you and your dermatologist a starting map. From there, any new mole or any change to an existing one has a known reference point, making it far easier to catch problems early, when melanoma is almost always curable.